10,000
Participants
Start Date
May 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy
Follow-up visits at baseline, 3-months, and 1-year
NOT_YET_RECRUITING
University of Bologna, Bologna
NOT_YET_RECRUITING
"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone", Palermo
RECRUITING
Ss. Cyril and Methodius University in Skopje, University Clinic, Skopje
RECRUITING
University of Belgrade, Clinical Center of Serbia, Belgrade
RECRUITING
University of Belgrade, Clinical Hospital Center Bezanijska kosa, Belgrade
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
OTHER
University of Bologna
OTHER